Analyst consensus rating
Cabaletta Bio, Inc. Analyst Consensus Rating
CABA analyst consensus rating, coverage count and price target evidence.
Direct answer
Cabaletta Bio, Inc.'s consensus rating is none.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $13.38.
Forecast evidence checked August 12, 2026.
Get free Cabaletta Bio, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.79
- Average price target
- $13.38
- High price target
- $30.00
- Low price target
- $4.00
- Target upside
- +379.4%
- Consensus rating
- none
- Analysts
- 8
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026